rs142235256
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_006514.4(SCN10A):c.1430C>T(p.Pro477Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00075 in 1,613,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P477S) has been classified as Uncertain significance.
Frequency
Consequence
NM_006514.4 missense
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN10A | NM_006514.4 | c.1430C>T | p.Pro477Leu | missense_variant | Exon 11 of 28 | ENST00000449082.3 | NP_006505.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.1430C>T | p.Pro477Leu | missense_variant | Exon 11 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.1430C>T | p.Pro477Leu | missense_variant | Exon 10 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.1457C>T | p.Pro486Leu | missense_variant | Exon 11 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152114Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000517 AC: 130AN: 251480 AF XY: 0.000581 show subpopulations
GnomAD4 exome AF: 0.000789 AC: 1153AN: 1461712Hom.: 0 Cov.: 31 AF XY: 0.000810 AC XY: 589AN XY: 727160 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000381 AC: 58AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74422 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge
not specified Benign:1
Variant summary: SCN10A c.1430C>T (p.Pro477Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00052 in 251480 control chromosomes, predominantly at a frequency of 0.00091 within the Non-Finnish European subpopulation in the gnomAD database. The allele frequency suggests that the variant is likely not associated with high a penetrance, severe, dominant disease phenotype. To our knowledge, no occurrence of c.1430C>T in individuals affected with Episodic pain syndrome, familial, 2 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 240663). Based on the evidence outlined above, the variant was classified as likely benign.
Episodic pain syndrome, familial, 2 Benign:1
Brugada syndrome Benign:1
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at